Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis-Reference-Cited by-同舟云学术

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis

Published:2009-08 Issue:8 Volume:31 Page:1641-1651
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Davidson Jaime A.,Liebl Andreas,Christiansen Jens S.,Fulcher Greg,Ligthelm Robert J.,Brown Paul,Gylvin Titus,Kawamori Ryuzo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes [published correction appears in Diabetes Care. 2006;49:2816–2818];Nathan;Diabetes Care,2006

2. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force;Jellinger;Endocr Pract,2007

3. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education;Wild;Patient Educ Couns,2007

4. Premixed insulin treatment for type 2 diabetes: Analogue or human?;Garber;Diabetes Obes Metab,2007

5. Efficacy of biphasic insulin aspart in patients with type 2 diabetes;Halimi;Clin Ther,2005

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

2. Investigation on Anti-diabetic Efficacy of a Cucurbitaceae Food Plant from the North-East Region of India: Exploring the Molecular Mechanism through Modulation of Oxidative Stress and Glycosylated Hemoglobin (HbA1c);Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-02

3. Real‐world study of the concomitant use of biphasic insulin as part 30/70 with GLP‐1 receptor agonist versus first‐generation basal insulin with GLP‐1 receptor agonist in type 2 diabetes;Diabetic Medicine;2023-12-13

4. Comparison of Insulin Analogs and Human Insulins: A Narrative Review;Journal of Diabetes and Endocrine Practice;2023-08-10

5. Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran;Journal of Diabetes & Metabolic Disorders;2023-04-08